Key points are not available for this paper at this time.
Blood-based AD biomarker concentrations are associated with pathological and clinical diagnoses and can predict future development of clinical AD, providing evidence that they can be incorporated into multi-ethnic, community-based studies.
Brickman et al. (Sat,) studied this question.